Sirio Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	541.55	636.03	534.49	1,502	715.54	216.7
Short-Term Investments	53.45	25.17	20	109.26	-	-
Trading Asset Securities	10.41	115.2	200.66	79.13	530.77	473.49
Cash & Short-Term Investments	605.41	776.4	755.14	1,690	1,246	690.2
Cash Growth	-5.02%	2.81%	-55.32%	35.60%	80.57%	74.56%
Accounts Receivable	848.98	702.53	652.86	476.96	372.33	307.1
Other Receivables	12.6	20.81	4.99	4.45	4.27	3.13
Receivables	861.58	723.34	657.85	481.41	376.6	310.22
Inventory	548.57	481.66	481.06	232.58	239.61	266.77
Other Current Assets	45.79	41.54	38.87	28.58	51.99	56.64
Total Current Assets	2,061	2,023	1,933	2,433	1,915	1,324
Property, Plant & Equipment	2,264	2,093	1,913	1,332	1,173	768.05
Long-Term Investments	159.4	52.44	94.11	-	337.79	152.22
Goodwill	431.98	417.1	420.73	163.05	158.59	176.28
Other Intangible Assets	523.15	525.92	544.84	178.33	160.75	128.97
Long-Term Deferred Tax Assets	115.71	81.36	32.48	13.75	16.31	33.75
Long-Term Deferred Charges	259.36	258.14	201.92	59.45	53	48.55
Other Long-Term Assets	62.57	34.66	55.99	7.14	6.57	17.98
Total Assets	5,878	5,486	5,196	4,186	3,820	2,650
Accounts Payable	458.75	393.43	398.13	259.25	195.71	199.52
Accrued Expenses	99.51	92.51	104.39	152.33	79.6	71.21
Short-Term Debt	129.26	54.82	-	0.16	0.12	1.61
Current Portion of Long-Term Debt	80.78	40.59	21.25	-	-	33.1
Current Portion of Leases	-	27.09	42.8	7.26	5.19	-
Current Income Taxes Payable	64.17	48.07	11.39	11.03	10.18	21.58
Current Unearned Revenue	39.73	36.92	53.13	25.83	28.22	43.11
Other Current Liabilities	216.71	131.1	120.04	13.84	13.43	16.93
Total Current Liabilities	1,089	824.54	751.13	469.69	332.44	387.06
Long-Term Debt	1,172	1,156	1,049	908.36	852.28	-
Long-Term Leases	324.29	328.39	256.16	21.14	16.68	-
Long-Term Unearned Revenue	72.19	59.7	65.68	62.4	61.48	65.25
Long-Term Deferred Tax Liabilities	14.78	15.15	28.08	22.69	12.44	14.64
Other Long-Term Liabilities	456.12	461.44	479.47	0.01	-	-
Total Liabilities	3,128	2,845	2,630	1,484	1,275	466.94
Common Stock	307.32	235.87	181.56	180.5	180.17	120
Additional Paid-In Capital	451.99	500.7	547.5	1,048	1,045	1,081
Retained Earnings	1,730	1,623	1,496	1,278	1,138	978.14
Treasury Stock	-66.16	-54.31	-44.53	-	-	-
Comprehensive Income & Other	230.47	200.88	209.37	195.13	181.35	3.75
Total Common Equity	2,654	2,506	2,390	2,702	2,545	2,183
Minority Interest	95.62	135.36	176.14	-	0.01	0.01
Shareholders' Equity	2,750	2,641	2,566	2,702	2,545	2,183
Total Liabilities & Equity	5,878	5,486	5,196	4,186	3,820	2,650
Total Debt	1,706	1,607	1,369	936.9	874.26	34.71
Net Cash (Debt)	-1,101	-830.1	-614.1	753.08	372.05	655.49
Net Cash Growth	-	-	-	102.42%	-43.24%	121.73%
Net Cash Per Share	-3.61	-2.73	-2.02	2.45	1.16	2.14
Filing Date Shares Outstanding	305.36	306.79	304.67	305.04	304.49	304.2
Total Common Shares Outstanding	305.36	304.96	304.67	305.04	304.49	304.2
Working Capital	972.44	1,198	1,182	1,963	1,582	936.77
Book Value Per Share	8.69	8.22	7.84	8.86	8.36	7.18
Tangible Book Value	1,699	1,563	1,424	2,360	2,225	1,877
Tangible Book Value Per Share	5.56	5.12	4.68	7.74	7.31	6.17
Buildings	-	1,067	1,000	890.28	528.67	478.54
Machinery	-	1,390	1,242	974.19	773.89	645.85
Construction In Progress	-	238.4	186.94	69.28	365.12	117.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.